ClinicalTrials.gg
Drug

Hexaminolevulinate hydrochloride clinical trials

Also written Hexvix, hexaminolevulinate and Cysview.

studies test it
20
open now
3
in phase 3
8
first study started
2001

How each study uses hexaminolevulinate hydrochloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the hexaminolevulinate hydrochloride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 May 2010 · CYSVIEW KIT · NDA 022555 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Hexaminolevulinate (HAL)
3
Hexaminolevulinate Hydrochloride
2

Brand

Hexvix
7
Cysview
3

Other names

hexaminolevulinate
5
Hexaminolevulinate HCL
2

Studies by the year they started

20 studies that test it; most in 2009 (3)

Studies that test hexaminolevulinate hydrochloride, by start year
YearStudies
20011
20052
20062
20081
20093
20112
20152
20161
20171
20181
20221
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
9
Phase 3
8
Phase 4
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 12 · Other 8

Photocure (11) · Joint Authority for Päijät-Häme Social and Health Care (1) · Oslo University Hospital (1) · Edward Messing (1) · Jørgen Bjerggaard Jensen (1) · Tongji Hospital (1) · Johns Hopkins University (1) · University of Roma La Sapienza (1)

Often tested with

Tested in the same studies.

BF-200 ALA (1) · Aminolevulinic Acid (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test hexaminolevulinate hydrochloride, phase 3 first.

Studies

Open first, then newest update. How each study uses hexaminolevulinate hydrochloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 20

What changed recently

From the registry's own updates since Oct 21, 2026.

Newly registered1

Codes

What other systems call hexaminolevulinate hydrochloride · ClinicalTrials.gg INT004302

  • MeSH (NLM) C4199245-aminolevulinic acid hexyl esterConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) D4F329SL1OHEXAMINOLEVULINATE HYDROCHLORIDEConfirmed FDA, Wikidata
  • RxNorm 1426871Confirmed FDA, Wikidata
  • Wikidata Q27276092hexaminolevulinate hydrochlorideConfirmed FDA, Wikidata
  • NCI Thesaurus C73601Hexaminolevulinate HydrochlorideOne source FDA

Also registered as hexaminolevulinate (UNII G7H20TKI67 · RxNorm 1426872).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.